Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s):  CLAZF

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.


TSXV:CLAS.H - Post by User

Comment by PTBaileyon Sep 16, 2021 9:58am
83 Views
Post# 33867917

RE:claritasinvestors.com, Dickk Move Drew you fricken Assole

RE:claritasinvestors.com, Dickk Move Drew you fricken Assole
Dude51 wrote: Looks like because of my comments yesterday about CLAS and the constant non news coming from these guys got me banded from the claritas investors site. One of the main reasons I decided to try a different approach with CLAS was I read an article published on Drew assole's site by a scientists that works in the cancer research field. He disputes Drew and CLAS and there statements about how great R-107 is. Basically he called CLAS Management shysters and gives a very good point to the affect the CLAS management are liers and disputes the major claim that R-107 is unique. 
Drew ASSOLE therefore decided to ban me from their site. Did not like the fact that on another website Stockwatch I had mentioned my distain for CLAS management that I had reversed my attitude toward CLAS on another website. So DICKK DREW bans me. Whats the matter DICKK DREW you don't like opinions ASSOLE?
 "Forbidden

You don't have permission to access this resource.

Additionally, a 403 Forbidden error was encountered while trying to use an ErrorDocument to handle the request."

Go to his site read, the article from buddy "investor" something was his handle, if ASSOLE DREW hasn't pulled it because buddy disagreed with the NARRATIVE of BS coming from CLAS.

Did he block you because you disagreed  with him or because you violate the group rules? Seems to me based on your comments here is may have been the rules. I see lots of post that don't agree with Drew.

 1. Must be, and/or want to be, a Claritas Investor.
2. No trolling or flame baiting.
3. Treat others with respect.
4. Not being disrespectful or slanderous towards admin or company officials"


<< Previous
Bullboard Posts
Next >>